Volume 119, Issue 6, Pages (December 2000)

Slides:



Advertisements
Similar presentations
Serum immunoglobulin a from patients with celiac disease inhibits human T84 intestinal crypt epithelial cell differentiation Tuula Halttunen, Markku Mäki.
Advertisements

Volume 115, Issue 4, Pages (October 1998)
Volume 134, Issue 7, Pages (June 2008)
Dietary extra virgin olive oil polyphenols supplementation modulates DSS-induced chronic colitis in mice  Susana Sánchez-Fidalgo, Ana Cárdeno, Marina.
Extra-virgin olive oil diet and mild physical activity prevent cartilage degeneration in an osteoarthritis model: an in vivo and in vitro study on lubricin.
STAT4 Knockout Mice Are More Susceptible to Concanavalin A–Induced T-Cell Hepatitis  Yan Wang, Dechun Feng, Hua Wang, Ming-Jiang Xu, Ogyi Park, Yongmei.
Volume 122, Issue 2, Pages (February 2002)
Volume 114, Issue 5, Pages (May 1998)
This Month in Gastroenterology
Volume 122, Issue 2, Pages (February 2002)
Volume 16, Issue 3, Pages (July 2016)
Volume 123, Issue 5, Pages (November 2002)
Volume 122, Issue 5, Pages (May 2002)
H. Lepidi, F. Gouriet, D. Raoult  Clinical Microbiology and Infection 
Volume 68, Issue 6, Pages (December 2005)
Volume 117, Issue 3, Pages (September 1999)
Volume 120, Issue 5, Pages (April 2001)
Volume 44, Issue 4, Pages (April 2006)
Volume 53, Issue 5, Pages (November 2010)
Volume 150, Issue 3, Pages (March 2016)
Volume 122, Issue 4, Pages (April 2002)
Volume 120, Issue 5, Pages (April 2001)
Ira J. Fox, Stephen C. Strom  Gastroenterology 
Volume 117, Issue 6, Pages (December 1999)
Volume 124, Issue 1, Pages (January 2003)
Volume 123, Issue 4, Pages (October 2002)
Volume 137, Issue 4, Pages e5 (October 2009)
Volume 134, Issue 7, Pages (June 2008)
Volume 130, Issue 2, Pages (February 2006)
Volume 122, Issue 5, Pages (May 2002)
Volume 130, Issue 4, Pages (April 2006)
Volume 120, Issue 6, Pages (May 2001)
Volume 44, Issue 4, Pages (April 2006)
Volume 129, Issue 5, Pages (November 2005)
Involvement of OX40-OX40L interactions in the intestinal manifestations of the murine acute graft-versus-host disease  Eckhard Stüber, Alexander von Freier,
Volume 119, Issue 6, Pages (December 2000)
Volume 124, Issue 3, Pages (March 2003)
Volume 135, Issue 1, Pages (July 2008)
Volume 114, Issue 3, Pages (March 1998)
Localization of the Wilson's disease protein in human liver
Volume 71, Issue 10, Pages (May 2007)
Daniel F. Wallace, Lesa Summerville, V. Nathan Subramaniam 
Volume 53, Issue 5, Pages (November 2010)
Volume 123, Issue 4, Pages (October 2002)
Volume 135, Issue 2, Pages (August 2008)
Volume 77, Issue 9, Pages (May 2010)
Volume 122, Issue 2, Pages (February 2002)
Volume 122, Issue 3, Pages (March 2002)
Volume 134, Issue 5, Pages (May 2008)
Volume 10, Issue 6, Pages (December 2004)
Epidermal growth factor and transforming growth factor α down-regulate human gastric lipase gene expression  Eric Tremblay, Jean René Basque, Nathalie.
Volume 124, Issue 3, Pages (March 2003)
This Month in Gastroenterology
The Function of Nitric Oxide in Wound Repair: Inhibition of Inducible Nitric Oxide- Synthase Severely Impairs Wound Reepithelialization  Birgit Stallmeyer,
AGA technical review on nonalcoholic fatty liver disease
Volume 119, Issue 6, Pages (December 2000)
Identification and isolation of candidate human colonic clonogenic cells based on cell surface integrin expression  Koji Fujimoto, R.Daniel Beauchamp,
Ex vivo gene therapy using bone marrow-derived cells: combined effects of intracerebral and intravenous transplantation in a mouse model of niemann–pick.
Volume 130, Issue 2, Pages (February 2006)
Aiden C.J. Marshall, Frank Alderuccio, Ban-Hock Toh  Gastroenterology 
Volume 119, Issue 6, Pages (December 2000)
Volume 124, Issue 1, Pages (January 2003)
Volume 17, Issue 23, Pages (December 2007)
Volume 80, Issue 5, Pages (September 2011)
Hong Du, Mark Levine, Chandrashekar Ganesa, David P. Witte, Edward S
Y. Castier, S. Lehoux, Y. Hu, G. Fonteinos, A. Tedgui, Q. Xu 
Volume 71, Issue 1, Pages (July 2019)
Fragment N expression does not affect islet morphology and cellularity
Genetic EGFR ablation in K-RAS–mutated lung AC reduces tumor growth
Volume 120, Issue 4, Pages (March 2001)
Presentation transcript:

Volume 119, Issue 6, Pages 1720-1730 (December 2000) Correction of liver disease by hepatocyte transplantation in a mouse model of progressive familial intrahepatic cholestasis  J.Marleen L. De Vree, *, Roel Ottenhoff, *, Piter J. Bosma, *, Alexander J. Smith, *,§, Jan Aten, ‡, Ronald P.J. Oude Elferink, *  Gastroenterology  Volume 119, Issue 6, Pages 1720-1730 (December 2000) DOI: 10.1053/gast.2000.20222 Copyright © 2000 American Gastroenterological Association Terms and Conditions

Fig. 1 (A) Patient with PFIC type 3 (cryosection stained for Ki67); (B) mdr2(−/−) mouse on a cholate-supplemented diet (paraffin-embedded section, stained for PCNA). The arrows indicate proliferating hepatocytes. (C–H) Immunohistochemical detection of MDR3-expressing hepatocytes in mdr2(−/−) mice using P3II26, a monoclonal antibody against MDR3 P-gp. (C) One week after transplantation (arrows indicate MDR3-expressing hepatocytes); (D) 8 weeks after transplantation on a cholate-supplemented diet; (E) 16 weeks after transplantation on a control diet; (F) 16 weeks after transplantation on a cholate-supplemented diet; (G) 50 weeks after transplantation on control diet; (H) 50 weeks after transplantation on a cholate-supplemented diet. (Original magnifications: 50× [C]; 25× [A, B, D, F]; 16× [E, G, H].) Gastroenterology 2000 119, 1720-1730DOI: (10.1053/gast.2000.20222) Copyright © 2000 American Gastroenterological Association Terms and Conditions

Fig. 2 Lipid secretion after hepatocyte transplantation and repopulation in mdr2(−/−) mice. Mice were transplanted with MDR3-expressing hepatocytes and fed (A–C) a control diet or (D–F) a cholate-supplemented diet. ●, Data from transplanted mdr2(−/−) mice; ○, the same parameter in mdr2(+/+) fed the same diet for 6 weeks. (A and D) Phospholipid secretion (absolute values); (B and E) cholesterol secretion (absolute values); (C and F) phospholipid/bile salt ratio. The data represent means ± SD and are derived from 5, 3, 4, 4, and 6 animals in the control diet group after 1, 4, 8, 16, and 52 weeks, respectively, and from 4 animals at each time point in the cholate-fed group. Gastroenterology 2000 119, 1720-1730DOI: (10.1053/gast.2000.20222) Copyright © 2000 American Gastroenterological Association Terms and Conditions

Fig. 3 Number of MDR3-expressing cells in mdr2(−/−) livers at various times after transplantation. Frozen sections were prepared from 4 different lobes of each mouse and stained with P3II26. The number of MDR3-expressing cells in each positive field was counted. ▿, Animals on a control diet; ▾, animals on a cholate-supplemented diet. The data represent means ± SD are derived from the same numbers of animals as in Figure 2. Gastroenterology 2000 119, 1720-1730DOI: (10.1053/gast.2000.20222) Copyright © 2000 American Gastroenterological Association Terms and Conditions

Fig. 4 The relationship between the number of MDR3-expressing hepatocytes per positive field (the mean of all counted fields in 4 lobes per mouse; see Figure 3) and the biliary phospholipid secretion (see Figure 2) for each mouse. Data are from individual mice on a control diet (▿) or a cholate-supplemented diet (▾). The correlation coefficient (r2) for the combined data was 0.832 (n = 39), which is highly significant (P < 0.001). Gastroenterology 2000 119, 1720-1730DOI: (10.1053/gast.2000.20222) Copyright © 2000 American Gastroenterological Association Terms and Conditions

Fig. 5 Parameters of liver pathology at various time points after transplantation of MDR3-expressing hepatocytes in mdr2(−/−) mice. (A and B) Histopathologic score in mdr2(−/−) mice at different time points after hepatocyte transplantation on control and cholate-supplemented diets. The scoring was performed as described in Materials and Methods and a previous report.16 A maximum score of 15 can be reached, indicating strong pathology. (A) Mice on a control diet; (B) mice on a cholate-supplemented diet. (C and D) Serum alkaline phosphatase activity in transplanted mdr2(−/−) mice. (C) Mice on a control diet; (D) mice on a cholate-supplemented diet. Note that the ordinate has a logarithmic scale. Closed symbols represent transplanted mdr2(−/−) mice; open symbols represent untransplanted mdr2(−/−) mice kept under identical conditions. Gastroenterology 2000 119, 1720-1730DOI: (10.1053/gast.2000.20222) Copyright © 2000 American Gastroenterological Association Terms and Conditions

Fig. 6 Liver histology 1 year after hepatocyte transplantation in (A and C) a transplanted mdr2(−/−) mouse on a control diet and (B and D) a transplanted mouse on a cholate-supplemented diet. (A and B) Immunohistochemical detection of proliferating hepatocytes by PCNA staining (original magnification 25×). (C and D) Liver histology 1 year after hepatocyte transplantation (H&E staining; original magnification 25×). Reversal of liver pathology was observed in transplanted mice on a control diet (C), in contrast to the sustained liver pathology in mice on a cholate-supplemented diet (D). Gastroenterology 2000 119, 1720-1730DOI: (10.1053/gast.2000.20222) Copyright © 2000 American Gastroenterological Association Terms and Conditions

Fig. 7 Immunohistochemical detection of transplanted mdr2(+/+) hepatocytes. Mdr2(−/−) mice were transplanted with normal mdr2(+/+) hepatocytes and fed a control diet for 6 months. Liver tissue was stained with REG3, a polyclonal antibody against mdr2 P-gp (original magnification 33×). Gastroenterology 2000 119, 1720-1730DOI: (10.1053/gast.2000.20222) Copyright © 2000 American Gastroenterological Association Terms and Conditions